OTCMKTS:CRLBF Cresco Labs (CRLBF) Stock Forecast, Price & News $2.09 -0.01 (-0.48%) (As of 09/22/2023 08:53 PM ET) Add Compare Share Share Today's Range$1.96▼$2.1450-Day Range$1.02▼$2.6852-Week Range$1.00▼$4.20Volume303,800 shsAverage Volume699,712 shsMarket Capitalization$722.35 millionP/E RatioN/ADividend YieldN/APrice Target$16.05 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestProfileAnalyst RatingsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort Interest Cresco Labs MarketRank™ ForecastAnalyst RatingHold2.38 Rating ScoreUpside/Downside667.9% Upside$16.05 Price TargetShort InterestHealthy0.42% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.06Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.21) to ($0.09) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.78 out of 5 stars 3.2 Analyst's Opinion Consensus RatingCresco Labs has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 3 buy ratings, 5 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.05, Cresco Labs has a forecasted upside of 667.9% from its current price of $2.09.Amount of Analyst CoverageCresco Labs has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.42% of the outstanding shares of Cresco Labs have been sold short.Short Interest Ratio / Days to CoverCresco Labs has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cresco Labs has recently increased by 15.37%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCresco Labs does not currently pay a dividend.Dividend GrowthCresco Labs does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRLBF. Previous Next 2.2 News and Social Media Coverage News SentimentCresco Labs has a news sentiment score of -0.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Cresco Labs this week, compared to 2 articles on an average week.Search Interest8 people have searched for CRLBF on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.MarketBeat Follows17 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 183% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cresco Labs insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.14% of the stock of Cresco Labs is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cresco Labs are expected to grow in the coming year, from ($0.21) to ($0.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cresco Labs is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cresco Labs is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCresco Labs has a P/B Ratio of 1.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cresco Labs (OTCMKTS:CRLBF) StockCresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. Cresco Labs Inc. was incorporated in 1990 and is headquartered in Chicago, Illinois.Read More CRLBF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRLBF Stock News HeadlinesSeptember 24, 2023 | americanbankingnews.comBright Green (NASDAQ:BGXX) and Cresco Labs (OTCMKTS:CRLBF) Critical ReviewSeptember 21, 2023 | finance.yahoo.comCresco Labs Expands Florida Brand Portfolio with Launch of FloraCal and Cresco Live Rosin and Flower ProductsSeptember 25, 2023 | UNKNOWN (Ad)Top Wellness Nasdaq Stock for 2023Cutting-Edge Ai-Based Technology Is Set to Disrupt the Womens Wellness SpaceSeptember 19, 2023 | americanbankingnews.comCresco Labs Inc. (OTCMKTS:CRLBF) Receives Average Rating of "Hold" from BrokeragesSeptember 16, 2023 | msn.comCresco marijuana facility in Wawarsing has yet to create first 75 promised jobs, but maintains a commitment to the projectSeptember 13, 2023 | msn.comWhy Canopy Growth, Aurora Cannabis, and Cresco Labs Stocks Sank TodaySeptember 12, 2023 | markets.businessinsider.comCresco Labs Takes On Trulieve As Major Competitor In Florida Where Weed Market Is Poised To ExplodeSeptember 12, 2023 | finance.yahoo.comCresco Labs Opens 33rd Florida Sunnyside in Jacksonville, 70th Store NationwideSeptember 25, 2023 | UNKNOWN (Ad)Top Wellness Nasdaq Stock for 2023Cutting-Edge Ai-Based Technology Is Set to Disrupt the Womens Wellness SpaceSeptember 7, 2023 | markets.businessinsider.comWeed Ads On Spotify? This Cannabis Giant Makes It Happen Via New PartnershipSeptember 7, 2023 | finance.yahoo.comCresco Labs Launches First-Ever Cannabis Advertisements on Spotify, the World’s Most Popular Audio Streaming Subscription ServiceSeptember 5, 2023 | msn.comWhy Cresco Labs Stock Wafted Nearly 5% Higher TodaySeptember 5, 2023 | benzinga.comEXCLUSIVE: How Federal Cannabis Reclassification Could Transform Business Finances, Insights From Cresco Labs' CEOAugust 18, 2023 | benzinga.comCresco Labs And Temple University Join Forces To Research The Untapped Medical Benefits Of CannabisAugust 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on NA Companies: Cresco Labs (OtherCRLBF) and TJX Companies (TJX)August 16, 2023 | msn.comCresco Labs Inc. (CRLBF) Reports Q2 Loss, Tops Revenue EstimatesAugust 16, 2023 | msn.comWhy Marijuana Stock Cresco Labs Jumped TodayAugust 16, 2023 | bizjournals.comCresco Labs retains No. 1 market share on cannabis products in IllinoisAugust 16, 2023 | seekingalpha.comCresco Labs reports Q2 resultsAugust 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on NA Companies: Cresco Labs (OtherCRLBF) and Target (TGT)August 16, 2023 | markets.businessinsider.comCresco Labs Reports Slight Sequential Improvement In Q2, YoY Drop In Revenue And Gross Profit As Net Loss GrowsAugust 16, 2023 | finance.yahoo.comCresco Labs Reports Second Quarter 2023 ResultsAugust 15, 2023 | benzinga.comEarnings Outlook For Cresco LabsAugust 15, 2023 | msn.comWhich Cannabis Stocks Are Best in 2023? We Name the Top 3August 10, 2023 | msn.comWill Cresco Labs Inc. (CRLBF) Report Negative Q2 Earnings? What You Should KnowAugust 7, 2023 | markets.businessinsider.comCresco Labs Opens Its 69th Cannabis DispensaryAugust 7, 2023 | finance.yahoo.comCresco Labs Expands Sunnyside in East Central Florida with New Store in Palm BaySee More Headlines Receive CRLBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address CRLBF Company Calendar Last Earnings8/16/2023Today9/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CRLBF CUSIPN/A CIK1832928 Webwww.crescolabs.com Phone312-929-0993FaxN/AEmployees3,200Year FoundedN/APrice Target and Rating Average Stock Price Forecast$16.05 High Stock Price Forecast$34.00 Low Stock Price Forecast$2.50 Forecasted Upside/Downside+667.9%Consensus RatingHold Rating Score (0-4)2.38 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.78) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-212,050,000.00 Net Margins-29.14% Pretax Margin-22.68% Return on Equity-9.52% Return on Assets-3.68% Debt Debt-to-Equity Ratio1.14 Current Ratio1.12 Quick Ratio0.61 Sales & Book Value Annual Sales$842.68 million Price / Sales0.86 Cash FlowN/A Price / Cash FlowN/A Book Value$1.70 per share Price / Book1.23Miscellaneous Outstanding Shares345,620,000Free FloatN/AMarket Cap$722.35 million OptionableNot Optionable Beta2.52 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Thomas J. Manning (Age 67)Exec. Chairman Comp: $800.05kMr. Charles Bachtell (Age 44)Co-Founder, CEO & Director Comp: $999.85kMr. Robert M. Sampson (Age 48)Co-Founder & Independent Director Mr. Dennis M. Olis (Age 60)Chief Financial Officer Comp: $622.85kMr. Ty Gent (Age 64)Chief Operating Officer Ms. Brenna Albert CPASr. VP and Controller of Accounting, Treasury & TaxMr. Zach Marburger (Age 38)Chief Information Officer Jake GravesMang. of Investor RelationsMr. John Schetz (Age 45)Gen. Counsel Mr. Jason Erkes (Age 52)Chief Communications Officer More ExecutivesKey CompetitorsCanopy GrowthNASDAQ:CGCCronos GroupNASDAQ:CRONbioteNASDAQ:BTMDUSANA Health SciencesNYSE:USNAAurora CannabisNYSE:ACBView All Competitors CRLBF Stock - Frequently Asked Questions Should I buy or sell Cresco Labs stock right now? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRLBF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRLBF, but not buy additional shares or sell existing shares. View CRLBF analyst ratings or view top-rated stocks. What is Cresco Labs' stock price forecast for 2023? 8 equities research analysts have issued 1-year price targets for Cresco Labs' shares. Their CRLBF share price forecasts range from $2.50 to $34.00. On average, they anticipate the company's stock price to reach $16.05 in the next year. This suggests a possible upside of 667.9% from the stock's current price. View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts. How have CRLBF shares performed in 2023? Cresco Labs' stock was trading at $1.80 on January 1st, 2023. Since then, CRLBF shares have increased by 16.1% and is now trading at $2.09. View the best growth stocks for 2023 here. Are investors shorting Cresco Labs? Cresco Labs saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,447,200 shares, an increase of 15.4% from the August 15th total of 1,254,400 shares. Based on an average daily trading volume, of 1,565,500 shares, the days-to-cover ratio is presently 0.9 days. View Cresco Labs' Short Interest. How were Cresco Labs' earnings last quarter? Cresco Labs Inc. (OTCMKTS:CRLBF) announced its quarterly earnings data on Wednesday, August, 16th. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by $0.02. The business earned $197.89 million during the quarter, compared to the consensus estimate of $194.60 million. Cresco Labs had a negative trailing twelve-month return on equity of 9.52% and a negative net margin of 29.14%. What is Cresco Labs' stock symbol? Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF." How do I buy shares of Cresco Labs? Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cresco Labs' stock price today? One share of CRLBF stock can currently be purchased for approximately $2.09. How much money does Cresco Labs make? Cresco Labs (OTCMKTS:CRLBF) has a market capitalization of $722.35 million and generates $842.68 million in revenue each year. The company earns $-212,050,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis. How many employees does Cresco Labs have? The company employs 3,200 workers across the globe. How can I contact Cresco Labs? Cresco Labs' mailing address is 400 West Erie Street, Chicago, IL 60654. The official website for the company is www.crescolabs.com. The company can be reached via phone at 312-929-0993 or via email at investors@crescolabs.com. This page (OTCMKTS:CRLBF) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cresco Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.